1119195

BioMarin Pharmaceutical Inc. — FEI 3010446870

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 28, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Rafael, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
683221 CFR 314.80(c)(2)Late submission of annual safety reports